Skip to research
Margin Monkey THEMARGINMONKEY Start my free trialTry free

Hinge Health (HNGE) stock in plain English

Free brief · no signupStart here
HNGEPublished Nov 11, 2026
Hinge Health Inc
Healthcare · Health Information Services
Sells digital physical therapy and specialty health clinics directly to self-insured employers and health plans.
Assets:
Enso wearable deviceProprietary FDA-cleared electrical nerve stimulation hardware for pain relief
3,270 enterprise clientsDirect contracts with corporate employers and commercial health plans
Computer vision trackingPatented smartphone camera motion analysis that guides exercise form
Locked assetIn the full report
Rated Nov 19, 2026

Every company we rate gets Strong Buy, Buy, Buy with Caution, Hold or Sell. Members see the rating for this company and the five scores behind it.

60
OPS ScoreOperating finances
Latest quote
-5.61%$108.10
$8.79B
54.5×
$800.86M

Change shown by the quote provider. Data may be delayed.

Financial statements, in plain wordsSales, profit, debt and cash, year by year
Published Nov 11, 2026Quotes updated Nov 20, 04:05 UTCOPS Score, TMM Score and the rating are research summaries, not advice or forecasts.
That was HNGE. The desk has 1,900+ more companies.Each one comes with its scores, its flags and the sources behind them.
7 days free · No card

What does Hinge Health (HNGE) do?

Hinge Health Inc (HNGE) is a U.S.-listed company in Healthcare (Health Information Services). What it does: Sells digital physical therapy and specialty health clinics directly to self-insured employers and health plans. Pairs wearable nerve stimulators with computer vision sensors to deliver remote joint and back pain clinics. It is worth $8.79B on the market and sold $800.86M over the last year.

Market cap
$8.79B
P/E ratio
54.5×
Annual sales
$800.86M
Sector
Healthcare
Industry
Health Information Services
Brief updated
Nov 11, 2026

Brands and businesses behind HNGE

  • Enso: Provides non-invasive electrical nerve stimulation to relieve musculoskeletal pain within employer-sponsored digital clinic memberships.

HNGE’s flags, in plain English

Each flag is a number from Hinge Health’s reports to the SEC or from market data, with the reason it matters. This brief was updated on Nov 11, 2026.

Wide Gross Margin

Gross margin of 85.7% after the cost of making its products. There is a large gap between what its products cost to make and what they sell for, and that gap pays for everything else.

Capital Works Hard

Earns 50.4% a year on the money it invests in the business. The money in the business, from shareholders and lenders together, earns a strong return. That points to a company that picks its investments well.

Low debt

Low debt, only 11% of shareholder equity. The company owes very little compared with what it earns, so a bad year is less likely to force its hand.

Runway Is Short

This year's bills are bigger than the cash and assets on hand to pay them. At its current rate of spending, its cash on hand covers only a limited stretch.

2 more green flags and 1 more risk note open with the free trial. Try it free for 7 days.

Questions about HNGE

How big is Hinge Health?

Hinge Health’s market cap is $8.79B: what all of its shares are worth together at today’s price. Its annual sales (revenue) are $800.86M: what customers paid the company over the last year, before any costs.

What is HNGE’s P/E ratio?

HNGE’s P/E ratio is 54.5×. Investors pay about 54.5 dollars for each dollar of the company’s yearly profit. A low number can mean a bargain or a problem, so read it next to the flags.

What could go wrong with HNGE?

Revenue depends heavily on enterprise employer benefits budgets, which face pressure during corporate cost-cutting cycles. That is one risk on Hinge Health’s card. Its first risk flag is Runway Is Short, explained above. The card holds 1 more risk note for trial accounts. A flag reads what the company reported. It does not predict the price.

Where do these numbers come from?

From Hinge Health’s own reports to the SEC (annual and quarterly) and from market data. Every company runs through the same scoring formula, and a reviewer spot-checks cards against the source data. HNGE’s filings on SEC.gov. The Margin Monkey is research, not advice.

Your first 7 days are free.Search all 1,900+ companies and open every card. Members also get the ratings, Picks and the TMM Score.
7 days free · No card